Shanghai Shen Lian Biomedical Corporation (SHA:688098)
China flag China · Delayed Price · Currency is CNY
6.00
+0.11 (1.87%)
Jun 9, 2025, 2:45 PM CST

SHA:688098 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
2,4192,2463,0723,2614,5346,592
Upgrade
Market Cap Growth
-1.96%-26.87%-5.79%-28.08%-31.23%-4.06%
Upgrade
Enterprise Value
2,3072,0972,9092,9314,0936,480
Upgrade
Last Close Price
5.895.477.427.7910.7215.50
Upgrade
PE Ratio
--97.4553.3641.1450.90
Upgrade
PS Ratio
8.227.4010.199.9212.6519.52
Upgrade
PB Ratio
1.701.582.042.183.084.72
Upgrade
P/TBV Ratio
1.851.722.202.263.144.84
Upgrade
P/FCF Ratio
3518.70504.58----
Upgrade
P/OCF Ratio
28.3925.14871.25358.7650.3159.00
Upgrade
EV/Sales Ratio
7.846.919.658.9211.4219.19
Upgrade
EV/EBITDA Ratio
66.8961.4232.0223.5426.5944.50
Upgrade
EV/EBIT Ratio
--105.0243.3837.1151.89
Upgrade
EV/FCF Ratio
3355.98471.14----
Upgrade
Debt / Equity Ratio
0.010.010.0000-
Upgrade
Debt / EBITDA Ratio
0.470.450.010.000.00-
Upgrade
Debt / FCF Ratio
23.343.48----
Upgrade
Asset Turnover
0.190.190.190.210.230.23
Upgrade
Inventory Turnover
1.161.170.770.741.000.87
Upgrade
Quick Ratio
3.493.916.336.045.546.82
Upgrade
Current Ratio
4.224.747.827.266.467.50
Upgrade
Return on Equity (ROE)
-3.40%-3.32%1.99%4.11%7.28%9.66%
Upgrade
Return on Assets (ROA)
-1.39%-1.34%1.08%2.64%4.43%5.27%
Upgrade
Return on Capital (ROIC)
-1.49%-1.43%1.15%2.84%4.80%5.76%
Upgrade
Return on Capital Employed (ROCE)
--1.80%4.50%7.40%8.90%
Upgrade
Earnings Yield
-1.88%-1.99%1.03%1.87%2.43%1.97%
Upgrade
FCF Yield
0.03%0.20%-4.11%-2.58%-2.16%-0.79%
Upgrade
Dividend Yield
0.59%-0.47%1.03%-0.65%
Upgrade
Payout Ratio
--103.98%60.25%37.03%26.14%
Upgrade
Buyback Yield / Dilution
-21.98%-3.23%3.28%0.20%2.31%-12.54%
Upgrade
Total Shareholder Return
-21.39%-3.23%3.75%1.23%2.31%-11.90%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.